News and Trends 9 Jan 2020 French Biotech Raises €19M to Hit Phase I with Cancer Immunotherapy …lead cancer immunotherapy into phase I testing. The candidate is an antibody that depletes T regulatory cells, or Tregs, which help tumors to evade the immune system. Alderaan expects to… January 9, 2020 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 29 Apr 2021 BMS’s Cancer Trial Showcases Potential for Checkpoint Inhibitors …inhibitors against cancer. Last month, the antibody drug relatlimab, developed by Bristol Myers Squibb, increased the progression-free survival of melanoma patients in phase III. These promising results did more than… April 29, 2021 - 5 minutesmins - By Mark Zipkin Share WhatsApp Twitter Linkedin Email
Infographics 19 Jan 2017 Infographic: A History of Approved Therapeutic Antibodies …With the recent advancements in antibody engineering, we can expect to see an improvement of their half-lives, effector functions or incorporation into antibody-drug conjugates. Since the first antibody hits the… January 19, 2017 - 1 minutemin - By Marie Godar Share WhatsApp Twitter Linkedin Email
In Depth 19 Jan 2022 Glycans Hit the Sweet Spot in Diagnostics …the glycosylation patterns of antibodies reveals much more insights into disease progression than just looking at antibody levels. For instance, while the levels of a type of antibody known as… January 19, 2022 - 5 minutesmins - By Sachin Rawat Share WhatsApp Twitter Linkedin Email
News and Trends 20 Nov 2018 Genentech and Immunocore Expand Partnership to Develop Cancer Immunotherapy …a fusion protein that combines engineered T cell proteins with antibody fragments. One end of the fusion protein binds with specific antigens on the surface of tumor cells, whereas the… November 20, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
More News! 3 Jul 2018 NASA Studies How Outer Space Affects the Immune System NASA is using an antibody assay to investigate the effect of space flight on white blood cells in astronauts on the International Space Station. The assay used by NASA measures… July 3, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 30 Apr 2019 Swiss Biotech Raises €11M to Develop Treatments for Liver Fibrosis Founded in March this year, Alentis Therapeutics has bagged a Series A round of €11.1M (CHF 12.5M) to develop antibody drugs treating liver fibrosis, which currently has no approved treatments…. April 30, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 1 Mar 2017 Swedish Oncology Biotech makes a Large IPO for its Peptides …Squibb and is the first antibody therapy against multiple myeloma and was approved in May 2016. Moreover, Janssen’s anti-CD38 antibody daratumumab reached its primary endpoint in the first Phase III… March 1, 2017 - 3 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email
News and Trends 6 Jan 2023 Transgene approved for IV oncolytic virus trial …powerful antitumor immune response, and a full length anti-CTLA4 antibody. By selectively targeting tumor cells and expressing IL-12 and the anti-CTLA4 antibody in the tumor microenvironment, TG6050 is expected to… January 6, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
In Depth 1 Sep 2025 Blood Cancer Awareness Month: What biotech holds in store …when paired with chemotherapy or venetoclax. A more experimental route is being pursued by Oryzon Genomics with its candidate iadademstat, a selective inhibitor of LSD1 (also known as KDM1A). LSD1… September 1, 2025 - 13 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 7 Sep 2022 Could COVID vaccine boosters become obsolete? …the original strain) are actually very effective in neutralizing the Delta and Omicron variants. According to our findings, the effectiveness of the first antibody, TAU-1109, in neutralizing the Omicron strain… September 7, 2022 - 5 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 21 Dec 2021 Argenx’s Potential Blockbuster Gets FDA Nod for Autoimmune Disease …marketed as Vyvgart, is an antibody fragment drug for use in adults with generalized myasthenia gravis. The FDA’s decision represents the first successful drug approval for argenx. According to Evaluate… December 21, 2021 - 4 minutesmins - By Anita Chakraverty Share WhatsApp Twitter Linkedin Email